Highly efficacious and safe neutralizing DNA aptamer of SARS-CoV-2 as an emerging therapy for COVID-19 disease

BACKGROUND: The paucity of SARS-CoV-2-specific virulence factors has greatly hampered the therapeutic management of patients with COVID-19 disease. Although available vaccines and approved therapies have shown tremendous benefits, the continuous emergence of new variants of SARS-CoV-2 and side effec...

Descripción completa

Detalles Bibliográficos
Autores principales: Ayass, Mohamad Ammar, Tripathi, Trivendra, Griko, Natalya, Pashkov, Victor, Dai, Jun, Zhang, Jin, Herbert, Fabian C., Ramankutty Nair, Ramya, Okyay, Tutku, Zhu, Kevin, Gassensmith, Jeremiah J., Abi-Mosleh, Lina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9800238/
https://www.ncbi.nlm.nih.gov/pubmed/36581924
http://dx.doi.org/10.1186/s12985-022-01943-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9800238/
https://www.ncbi.nlm.nih.gov/pubmed/36581924
http://dx.doi.org/10.1186/s12985-022-01943-7

Ejemplares similares